Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 3 art units • 5 examiners • 0 of 7 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
TCI Co., Ltd. has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 5 distinct examiners across 3 distinct art units, indicating that the workload is distributed among several examiners but remains concentrated within a limited number of examination groups.
CHEN, CATHERYNE is the busiest examiner, with 2 pending matters. The examiner handles more than one listed application, but the portfolio still requires coordination across other examiner assignments.
For counsel, the art-unit structure supports group-level review of recurring technical or claim issues. Examiner-specific response planning remains important because the applications are not handled by one examiner alone.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 2 (29%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHEN, CATHERYNE | 2 | 37.5% | +17.9% |
| SPAINE, ROBERT FRANKLIN | 2 | 75.0% | +0.0% |
| FERNANDEZ, SUSAN EMILY | 1 | 52.3% | +60.9% |
| TRAN, SUSAN T | 1 | 63.0% | +34.8% |
| MOREAU, NASHARA LOUISE | 1 | 66.7% | -80.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | CHEN, CATHERYNE | 14d |
| 19105296 | BIFIDOBACTERIUM BREVE, COMPOSITION COMPRISING BIFIDOBACTERIUM BREVE OR CULTURE THEREOF, AND USE OF BIFIDOBACTERIUM BREVE OR CULTURE THEREOF | FERNANDEZ, SUSAN EMILY | — |
| 18855329 | USE OF PRUNUS LANNESIANA EXTRACT FOR IMPROVING SKIN CONDITION AND BASAL METABOLIC RATE | CHEN, CATHERYNE | — |
| 18426360 | METHODS FOR ENHANCING SKIN RESISTANCE, IMPROVING SKIN SMOOTHNESS, OR IMPROVING SKIN BRIGHTNESS BY USING AMPELOPSIS GROSSEDENTATA LEAF EXTRACT | TRAN, SUSAN T | — |
| 18528783 | METHODS FOR RESISTING SKIN AGING BY USING KIWIBERRY EXTRACT | SPAINE, ROBERT FRANKLIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | CHEN, CATHERYNE | 14d |
| 19105296 | BIFIDOBACTERIUM BREVE, COMPOSITION COMPRISING BIFIDOBACTERIUM BREVE OR CULTURE THEREOF, AND USE OF BIFIDOBACTERIUM BREVE OR CULTURE THEREOF | FERNANDEZ, SUSAN EMILY | — |
| 18855329 | USE OF PRUNUS LANNESIANA EXTRACT FOR IMPROVING SKIN CONDITION AND BASAL METABOLIC RATE | CHEN, CATHERYNE | — |
| 18426360 | METHODS FOR ENHANCING SKIN RESISTANCE, IMPROVING SKIN SMOOTHNESS, OR IMPROVING SKIN BRIGHTNESS BY USING AMPELOPSIS GROSSEDENTATA LEAF EXTRACT | TRAN, SUSAN T | — |
| Art Unit | Apps |
|---|---|
| 1655 | 5 |
| 1651 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19105296 | BIFIDOBACTERIUM BREVE, COMPOSITION COMPRISING BIFIDOBACTERIUM BREVE OR CULTURE THEREOF, AND USE OF BIFIDOBACTERIUM BREVE OR CULTURE THEREOF | FERNANDEZ, SUSAN EMILY | 1651 | §101§112 | Non-Final OA | — | Pending | Feb 20, 2025 |
| 18855329 | USE OF PRUNUS LANNESIANA EXTRACT FOR IMPROVING SKIN CONDITION AND BASAL METABOLIC RATE | CHEN, CATHERYNE | 1655 | §102§112 | Non-Final OA | — | Pending | Oct 09, 2024 |
| 18426360 | METHODS FOR ENHANCING SKIN RESISTANCE, IMPROVING SKIN SMOOTHNESS, OR IMPROVING SKIN BRIGHTNESS BY USING AMPELOPSIS GROSSEDENTATA LEAF EXTRACT | TRAN, SUSAN T | 1615 | §102§103 | Final Rejection | — | Pending | Jan 30, 2024 |
| 18409817 | METHODS FOR IMPROVING SLEEP QUALITY, INCREASING MITOCHONDRIAL EXPRESSION, PROMOTING CELL REPAIRING, OR FIRMING SKIN BY USING SPARASSIA CRISPA EXTRACT | SPAINE, ROBERT FRANKLIN | 1655 | §103 | Final Rejection | 13d | Pending | Jan 11, 2024 |
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | CHEN, CATHERYNE | 1655 | §103§112 | Final Rejection | 14d | Pending | Dec 26, 2023 |
| 18528783 | METHODS FOR RESISTING SKIN AGING BY USING KIWIBERRY EXTRACT | SPAINE, ROBERT FRANKLIN | 1655 | §102§103§112 | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18518451 | METHOD FOR REGULATING IMMUNITY BY USING BLACK HULLESS BARLEY EXTRACT | MOREAU, NASHARA LOUISE | 1655 | §103 | Non-Final OA | 75d | Pending | Nov 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTCI Co., Ltd. has 7 pending office actions as of October 2026, spread across 3 art units and 5 examiners.
Catheryne Chen has the most, with 2 of TCI Co., Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
